[Clinical evaluation of disodium cromoglycate with beta-2-agonist in therapy of patients with atopic bronchial asthma (preliminary study)]. 1993

T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
II Kliniki Chorób Wewnetrznych Instytutu Medycyny Wewnetrznej Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej, Warszawie.

In 38 patients with atopic bronchial asthma DNCG (disodium cromoglycate) and DNCG comp. (disodium cromoglycate and reproterol hydrochloride) were applied in inhalation way. After 7 days course spirometric values were monitoring in all patients. Decrease of Raw values and increases of FEF50 and FEV1 were noticed in all patients, especially in asthmatics treated with DNCG comp. Obtained results suggest a good clinical effect and improvement of spirometric values in patients with atopic bronchial asthma during DNCG and DNCG comp. therapy.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009921 Metaproterenol A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM. Orciprenaline,Alotec,Alupent,Astmopent,Metaprel,Metaproterenol Polistirex,Metaproterenol Sulfate,Orciprenaline Sulfate,Polistirex, Metaproterenol
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
October 1997, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
August 1971, Harefuah,
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
January 1970, Folia allergologica,
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
April 1972, La Clinica terapeutica,
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
January 1972, Folia allergologica,
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
June 1968, Lancet (London, England),
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
July 1968, Lancet (London, England),
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
August 1968, Lancet (London, England),
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
July 1968, Lancet (London, England),
T Płusa, and B Mamełka, and A Chciałowski, and R Włodarczyk
August 1968, Lancet (London, England),
Copied contents to your clipboard!